Complete Genomics, a human genome sequencing company, has announced a new cancer grant program. Winning research applications will receive complete human genome sequencing of eight genomes—four tumor/normal pairs. Four winning entries will be chosen: two each from the United States and Europe.
Complete Genomics is accepting grant applications for cancer-specific research projects using its complete human genome sequencing service until July 29, 2011.
Applications will be evaluated by an internal panel of scientific experts at Complete Genomics. Winners will be notified by Aug. 12 and will be required to submit their samples by Sept. 16. All applicants will be eligible for a discount on their next complete human genome sequencing project.
"We are delighted to have the opportunity to provide pioneering scientists with complete human genome sequencing and research-ready data that they can immediately use to gain insights into the characterization and possible treatment of various cancers, " said Dr. Clifford Reid, chairman, president and CEO of Complete Genomics.